|
May 2
|
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 30
|
Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 29
|
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
|
|
Apr 25
|
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
|
|
Apr 17
|
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
|
|
Apr 12
|
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
|
|
Apr 2
|
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
|
|
Apr 1
|
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
|
|
Mar 25
|
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
|
|
Mar 22
|
Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
|
|
Mar 20
|
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
|
|
Mar 19
|
Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...
|
|
Mar 19
|
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
|
|
Mar 18
|
Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals
|
|
Mar 18
|
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
|
|
Mar 14
|
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
|
|
Mar 12
|
Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...
|
|
Mar 7
|
Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results
|
|
Mar 7
|
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|